Nitroso Escitalopram EP Impurity C
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Nitroso Escitalopram EP Impurity C

● Under Development

Katalog-Nr.::VE007929
CAS-Nr.::N/A
Summenformel::C19H16FN3O3
Molare Masse::353.35 g/mol

Zusätzliche Informationen zu Nitroso Escitalopram EP Impurity C

Parent drug

Escitalopram

IUPAC-Name

N-(3-(5-cyano-1-(4-fluorophenyl)-3-oxo-1, 3-dihydroisobenzofuran-1-yl)propyl)-N-methylnitrous amide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

O=NN(CCCC1(C2=CC=C(F)C=C2)OC(C3=C1C=CC(C#N)=C3)=O)C

InChI

InChI=1S/C19H16FN3O3/c1-23(22-25)10-2-9-19(14-4-6-15(20)7-5-14)17-8-3-13(12-21)11-16(17)18(24)26-19/h3-8,11H,2,9-10H2,1H3

Beschreibung

Nitroso Escitalopram EP Impurity C is an N-nitroso derivative of the secondary amine present in Escitalopram | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Escitalopram production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url